Preparation and Prosecution of Domestic and International Utility Patents, Patent Portfolio Management and Strategy, Opinions and Analysis re: Patentability, Infringement, Validity, Freedom-to-Operate and Due Diligence and Licensing
Biotechnology and Pharmaceuticals
Diana Hamlet-Cox, Ph.D., is a Director who focuses her practice in the biotechnology and pharmaceutical industries. Dr. Hamlet-Cox has extensive experience in a broad range of intellectual property matters — including patent prosecution, evaluating patentability and freedom-to-operate issues, preparing patent applications and designing U.S. and worldwide prosecution strategies to maximize the value of intellectual property assets, undertaking IP-related technology analysis and evaluation, counseling on due diligence and strategic business planning involving IP, and technology assessment.
Dr. Hamlet-Cox’s practice focuses on technologically complex matters, particularly relating to biotechnology and pharmaceutical agents, including antibody technologies; molecular biology, biological chemistry, genomics, proteomics, expression profiling, transgenic animals, drug discovery, steroid chemistry, and processes and formulations.
Dr. Hamlet-Cox, who is a registered U.S. patent attorney, worked as an associate in the firm for the first 11 years of her career until she left in 1999 to work in-house in the biotechnology industry. She was Vice President of Intellectual Property at Incyte Corp., where she managed the largest privately-held gene patent portfolio, as well as a microarray technology portfolio. In 2005, she was appointed Vice President and Chief Patent Counsel for Medarex, Inc., an antibody, antibody-drug conjugate and transgenics biotechnology company that was acquired by Bristol-Myers Squibb in 2009. She returned to the firm as a partner in 2010.
Dr. Hamlet-Cox’s years of in-house experience gives her a distinctive perspective on her clients’ approach to IP issues. She understands and supports her clients’ interests in prioritizing patent prosecutions and other projects based on cost and short- and long-term business objectives, as well as based on important legal issues that may affect a company’s entire portfolio; see, for example, her speaking engagements, publications and interviews regarding the gene patenting public policy issues during her tenure at Incyte.
Dr. Hamlet-Cox carried out her doctoral research in the Biological Chemistry Department at the UCLA Medical School, on histone protein structure and function.
George Mason University School of Law, Patent Law Specialty Track (J.D. 1992)
University of California Los Angeles Medical School, (Ph.D. Biological Chemistry/Molecular Biology 1985)
Yale University (B.S. Biology/Biochemistry 1975)
Membership and Affiliations
American Intellectual Property Law Association
Virginia State Bar (1992)
California State Bar (2000)
Admitted to practice before the United States Patent & Trademark Office (1988)
Speaking Engagements and Publications
Guest lecturer for George Mason University Law School Chemical Patent Practice Course, 2011 – present